Schoenfeld, D. A., Caulfield, J. I., Aizenbud, L., Perdigoto, A. L., Austin, M. R., & Mann, J. E. Response to 'NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors' by Xiang-Yu Meng. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSchoenfeld, David A., Jasmine I. Caulfield, Lilach Aizenbud, Ana Luisa Perdigoto, Matthew R. Austin, and Jacqueline E. Mann. Response to 'NLRC5 Germline Variants and Their Potential Role in Eliciting an Immune Response in Patients with Cancer Treated with Immune Checkpoint Inhibitors' by Xiang-Yu Meng. BMJ Publishing Group.
MLA (9th ed.) CitationSchoenfeld, David A., et al. Response to 'NLRC5 Germline Variants and Their Potential Role in Eliciting an Immune Response in Patients with Cancer Treated with Immune Checkpoint Inhibitors' by Xiang-Yu Meng. BMJ Publishing Group.